The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis

Christopher M. Cabello, Sarah D. Lamore, Warner B. Bair, Shuxi Qiao, Sara Azimian, Jessica L. Lesson, Georg T Wondrak

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Recent research suggests that altered redox control of melanoma cell survival, proliferation, and invasiveness represents a chemical vulnerability that can be targeted by pharmacological modulation of cellular oxidative stress. The endoperoxide artemisinin and semisynthetic artemisinin-derivatives including dihydroartemisinin (DHA) constitute a major class of antimalarials that kill plasmodium parasites through induction of iron-dependent oxidative stress. Here, we demonstrate that DHA may serve as a redox chemotherapeutic that selectively induces melanoma cell apoptosis without compromising viability of primary human melanocytes. Cultured human metastatic melanoma cells (A375, G361, LOX) were sensitive to DHA-induced apoptosis with upregulation of cellular oxidative stress, phosphatidylserine externalization, and activational cleavage of procaspase 3. Expression array analysis revealed DHAinduced upregulation of oxidative and genotoxic stress response genes (GADD45A, GADD153, CDKN1A, PMAIP1, HMOX1, EGR1) in A375 cells. DHA exposure caused early upregulation of the BH3-only protein NOXA, a proapototic member of the Bcl2 family encoded by PMAIP1, and genetic antagonism (siRNA targeting PMAIP1) rescued melanoma cells from apoptosis indicating a causative role of NOXA-upregulation in DHA-induced melanoma cell death. Comet analysis revealed early DHA-induction of genotoxic stress accompanied by p53 activational phosphorylation (Ser 15). In primary human epidermal melanocytes, viability was not compromised by DHA, and oxidative stress, comet tail moment, and PMAIP1 (NOXA) expression remained unaltered. Taken together, these data demonstrate that metastatic melanoma cells display a specific vulnerability to DHA-induced NOXAdependent apoptosis and suggest feasibility of future antimelanoma intervention using artemisinin-derived clinical redox antimalarials.

Original languageEnglish (US)
Pages (from-to)1289-1301
Number of pages13
JournalInvestigational New Drugs
Volume30
Issue number4
DOIs
StatePublished - Aug 2012

Fingerprint

dihydroartemisinin
Melanocytes
Antimalarials
Oxidation-Reduction
Melanoma
Apoptosis
Oxidative Stress
Up-Regulation
DNA Damage
Plasmodium
Phosphatidylserines

Keywords

  • Apoptosis
  • Dihydroartemisinin
  • Malignant melanoma
  • Oxidative stress
  • PMAIP1
  • Reactive oxygen species

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Oncology

Cite this

The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis. / Cabello, Christopher M.; Lamore, Sarah D.; Bair, Warner B.; Qiao, Shuxi; Azimian, Sara; Lesson, Jessica L.; Wondrak, Georg T.

In: Investigational New Drugs, Vol. 30, No. 4, 08.2012, p. 1289-1301.

Research output: Contribution to journalArticle

Cabello, Christopher M. ; Lamore, Sarah D. ; Bair, Warner B. ; Qiao, Shuxi ; Azimian, Sara ; Lesson, Jessica L. ; Wondrak, Georg T. / The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis. In: Investigational New Drugs. 2012 ; Vol. 30, No. 4. pp. 1289-1301.
@article{3cbfc3574d994ce8a51d9e0a6ee28245,
title = "The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis",
abstract = "Recent research suggests that altered redox control of melanoma cell survival, proliferation, and invasiveness represents a chemical vulnerability that can be targeted by pharmacological modulation of cellular oxidative stress. The endoperoxide artemisinin and semisynthetic artemisinin-derivatives including dihydroartemisinin (DHA) constitute a major class of antimalarials that kill plasmodium parasites through induction of iron-dependent oxidative stress. Here, we demonstrate that DHA may serve as a redox chemotherapeutic that selectively induces melanoma cell apoptosis without compromising viability of primary human melanocytes. Cultured human metastatic melanoma cells (A375, G361, LOX) were sensitive to DHA-induced apoptosis with upregulation of cellular oxidative stress, phosphatidylserine externalization, and activational cleavage of procaspase 3. Expression array analysis revealed DHAinduced upregulation of oxidative and genotoxic stress response genes (GADD45A, GADD153, CDKN1A, PMAIP1, HMOX1, EGR1) in A375 cells. DHA exposure caused early upregulation of the BH3-only protein NOXA, a proapototic member of the Bcl2 family encoded by PMAIP1, and genetic antagonism (siRNA targeting PMAIP1) rescued melanoma cells from apoptosis indicating a causative role of NOXA-upregulation in DHA-induced melanoma cell death. Comet analysis revealed early DHA-induction of genotoxic stress accompanied by p53 activational phosphorylation (Ser 15). In primary human epidermal melanocytes, viability was not compromised by DHA, and oxidative stress, comet tail moment, and PMAIP1 (NOXA) expression remained unaltered. Taken together, these data demonstrate that metastatic melanoma cells display a specific vulnerability to DHA-induced NOXAdependent apoptosis and suggest feasibility of future antimelanoma intervention using artemisinin-derived clinical redox antimalarials.",
keywords = "Apoptosis, Dihydroartemisinin, Malignant melanoma, Oxidative stress, PMAIP1, Reactive oxygen species",
author = "Cabello, {Christopher M.} and Lamore, {Sarah D.} and Bair, {Warner B.} and Shuxi Qiao and Sara Azimian and Lesson, {Jessica L.} and Wondrak, {Georg T}",
year = "2012",
month = "8",
doi = "10.1007/s10637-011-9676-7",
language = "English (US)",
volume = "30",
pages = "1289--1301",
journal = "Investigational New Drugs",
issn = "0167-6997",
publisher = "Kluwer Academic Publishers",
number = "4",

}

TY - JOUR

T1 - The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis

AU - Cabello, Christopher M.

AU - Lamore, Sarah D.

AU - Bair, Warner B.

AU - Qiao, Shuxi

AU - Azimian, Sara

AU - Lesson, Jessica L.

AU - Wondrak, Georg T

PY - 2012/8

Y1 - 2012/8

N2 - Recent research suggests that altered redox control of melanoma cell survival, proliferation, and invasiveness represents a chemical vulnerability that can be targeted by pharmacological modulation of cellular oxidative stress. The endoperoxide artemisinin and semisynthetic artemisinin-derivatives including dihydroartemisinin (DHA) constitute a major class of antimalarials that kill plasmodium parasites through induction of iron-dependent oxidative stress. Here, we demonstrate that DHA may serve as a redox chemotherapeutic that selectively induces melanoma cell apoptosis without compromising viability of primary human melanocytes. Cultured human metastatic melanoma cells (A375, G361, LOX) were sensitive to DHA-induced apoptosis with upregulation of cellular oxidative stress, phosphatidylserine externalization, and activational cleavage of procaspase 3. Expression array analysis revealed DHAinduced upregulation of oxidative and genotoxic stress response genes (GADD45A, GADD153, CDKN1A, PMAIP1, HMOX1, EGR1) in A375 cells. DHA exposure caused early upregulation of the BH3-only protein NOXA, a proapototic member of the Bcl2 family encoded by PMAIP1, and genetic antagonism (siRNA targeting PMAIP1) rescued melanoma cells from apoptosis indicating a causative role of NOXA-upregulation in DHA-induced melanoma cell death. Comet analysis revealed early DHA-induction of genotoxic stress accompanied by p53 activational phosphorylation (Ser 15). In primary human epidermal melanocytes, viability was not compromised by DHA, and oxidative stress, comet tail moment, and PMAIP1 (NOXA) expression remained unaltered. Taken together, these data demonstrate that metastatic melanoma cells display a specific vulnerability to DHA-induced NOXAdependent apoptosis and suggest feasibility of future antimelanoma intervention using artemisinin-derived clinical redox antimalarials.

AB - Recent research suggests that altered redox control of melanoma cell survival, proliferation, and invasiveness represents a chemical vulnerability that can be targeted by pharmacological modulation of cellular oxidative stress. The endoperoxide artemisinin and semisynthetic artemisinin-derivatives including dihydroartemisinin (DHA) constitute a major class of antimalarials that kill plasmodium parasites through induction of iron-dependent oxidative stress. Here, we demonstrate that DHA may serve as a redox chemotherapeutic that selectively induces melanoma cell apoptosis without compromising viability of primary human melanocytes. Cultured human metastatic melanoma cells (A375, G361, LOX) were sensitive to DHA-induced apoptosis with upregulation of cellular oxidative stress, phosphatidylserine externalization, and activational cleavage of procaspase 3. Expression array analysis revealed DHAinduced upregulation of oxidative and genotoxic stress response genes (GADD45A, GADD153, CDKN1A, PMAIP1, HMOX1, EGR1) in A375 cells. DHA exposure caused early upregulation of the BH3-only protein NOXA, a proapototic member of the Bcl2 family encoded by PMAIP1, and genetic antagonism (siRNA targeting PMAIP1) rescued melanoma cells from apoptosis indicating a causative role of NOXA-upregulation in DHA-induced melanoma cell death. Comet analysis revealed early DHA-induction of genotoxic stress accompanied by p53 activational phosphorylation (Ser 15). In primary human epidermal melanocytes, viability was not compromised by DHA, and oxidative stress, comet tail moment, and PMAIP1 (NOXA) expression remained unaltered. Taken together, these data demonstrate that metastatic melanoma cells display a specific vulnerability to DHA-induced NOXAdependent apoptosis and suggest feasibility of future antimelanoma intervention using artemisinin-derived clinical redox antimalarials.

KW - Apoptosis

KW - Dihydroartemisinin

KW - Malignant melanoma

KW - Oxidative stress

KW - PMAIP1

KW - Reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=84866741435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866741435&partnerID=8YFLogxK

U2 - 10.1007/s10637-011-9676-7

DO - 10.1007/s10637-011-9676-7

M3 - Article

VL - 30

SP - 1289

EP - 1301

JO - Investigational New Drugs

JF - Investigational New Drugs

SN - 0167-6997

IS - 4

ER -